Stephen James Read

Stephen James Read

Auto-generated profile, based on publicly available information

Stephen James Read

Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Stroke
Verified
Journal Article
Closed access
CPChris Plummer
Chris Plummer
RHRobert D. Henderson
Robert D. Henderson
JOJohn D. O'SUllivan
John D. O'SUllivan
SRStephen J. Read
Stephen J. Read
Background and Purpose—: Cerebrovascular disease can complicate head and neck radiotherapy and result in transient ischemic attack and ischemic stroke. Although the incidence of radiation vasculopathy is predicted to rise with improvements in median cancer survival, the pathogenesis, natural history, and management of the disease are ill defined. Methods—: We examined studies on the epidemiology, imaging, pathogenesis, and management of medium- and large-artery intra- and extra-cranial disease after head and neck radiotherapy. Controlled prospective trials and larger retrospective trials from the last 30 years were prioritized. Results—: The relative risk of transient ischemic attack or ischemic stroke is at least doubled by head and neck radiotherapy. Chronic radiation vasculopathy affecting medium and large intra- and extra-cranial arteries is characterized by increasing rates of hemodynamically significant stenosis with time from radiotherapy. Disease expression is the likely consequence of the combined radiation insult to the intima-media (accelerating atherosclerosis) and to the adventitia (injuring the vasa vasorum). Optimal medical treatment is not established. Carotid endarterectomy is confounded by the need to operate across scarred tissue planes, whereas carotid stenting procedures have resulted in high restenosis rates. Conclusions—: Head and neck radiotherapy significantly increases the risk of transient ischemic attack and ischemic stroke. Evidence-based guidelines for the management of asymptomatic and symptomatic (medium- and large-artery) radiation vasculopathy are lacking. Long-term prospective studies remain a priority, as the incidence of the problem is anticipated to rise with improvements in postradiotherapy patient survival.

1 February 2016 in Clinical Neurophysiology
Verified
Journal Article
Closed access
SFSimon Finnigan
Simon Finnigan
AWAndrew Wong
Andrew Wong
SRStephen Read
Stephen Read

20 December 2011 in International Journal of Stroke
Verified
Journal Article
Closed access
HMHenry Ma
Henry Ma
MPMark W. Parsons
Mark W. Parsons
SCSoren Christensen
Soren Christensen
BCBruce C. V. Campbell
Bruce C. V. Campbell
LCLeonid Churilov
Leonid Churilov
OIon behalf of the EXTEND investigators
on behalf of the EXTEND investigators

6 April 2004 in Brain
Verified
Journal Article
Open access
PDF file
RMR. Markus
R. Markus
DRD. C. Reutens
D. C. Reutens
SKS. Kazui
S. Kazui
SRS. Read
S. Read
PWP. Wright
P. Wright
GDGeoffrey Donnan
Geoffrey Donnan
In ischaemic stroke, expansion of the infarct core occurs at the expense of surrounding hypoxic, metabolically compromised tissue over a period of 24 h or more in a considerable proportion of patients. It is uncertain whether hypoxic tissue observed at later times after stroke onset retains the potential for survival or whether such survival has an impact on functional outcome. These factors may determine the effectiveness of therapeutic strategies aimed at salvaging this tissue. We tested the hypotheses that metabolically compromised hypoxic tissue observed within 48 h after onset of ischaemic stroke retains the potential for spontaneous survival and that the impact of such survival on functional outcome is time dependent. Consecutive patients presenting within 48 h of ischaemic stroke were studied with [18F]fluoromisonidazole, a ligand binding to hypoxic but viable tissue, and PET. Subjects were grouped into two time epochs, ≤12 and >12 h, based on the interval from stroke onset to the time of tracer injection, and had infarct volumes measured on CT/MRI at 7 days (n = 60). The total ischaemic volume (TIV) and the proportion of the TIV that spontaneously survived (surviving hypoxic volume ratio, SHVR) were defined from the co‐registered CT/MRI images. These volumetric measures were correlated with neurological outcome assessed at day 7–10 by percentage change in the National Institutes of Health Stroke Scale (ΔNIHSS), and at 3 months by Barthel Index (BI) and modified Rankin Score (mRS). Of 66 patients investigated, hypoxic tissue occurred in 33 and outcome data was available in 27. Hypoxic tissue constituted >20% of the TIV in 60% of studies ≤12 h and 16% >12 h. The spontaneously surviving proportion of the TIV (median 6.9%) or hypoxic tissue (median 45.9%) was not significantly different in patient subgroups studied ≤12 or >12 h after stroke onset. Spontaneous survival of hypoxic tissue (surviving hypoxic volume ratio) was associated with improved neurological outcome in both time epochs: ≤12 h, ΔNIHSS (r = 0.85, P < 0.01), day 90 BI (r = 0.86, P < 0.01) and day 90 mRS (r = –0.89, P < 0.01); >12 h, ΔNIHSS (r = 0.59, P < 0.01) and day 90 mRS (r = –0.46, P < 0.05). The finding that similar proportions of hypoxic tissue survived spontaneously within each time epoch suggests that its fate is not predetermined. The favourable neurological outcome associated with spontaneous survival of hypoxic tissue, even 12–48 h after stroke onset, suggests that the volume of hypoxic tissue that progressed to infarction may represent a valuable target for therapeutic intervention.

16 March 2010 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
JYJun Yan
Jun Yan
JGJudith Greer
Judith Greer
RHRenee Hull
Renee Hull
JOJohn D O'Sullivan
John D O'Sullivan
RHRobert D Henderson
Robert D Henderson
PMPamela Ann McCombe
Pamela Ann McCombe
Background: There is reported to be a decline in immune function and an alteration in the frequency of circulating lymphocytes with advancing age. There are also differences in ageing and lifespan between males and females. We performed this study to see if there were differences between males and females in the frequency of the different lymphocyte subsets with age.Results: Using flow cytometry we have examined different populations of peripheral blood leukocytes purified from healthy subjects with age ranging from the third to the tenth decade. We used linear regression analysis to determine if there is a linear relationship between age and cell frequencies. For the whole group, we find that with age there is a significant decline in the percentage of naïve T cells and CD8+T cells, and an increase in the percentage of effector memory cells, CD4+foxp3+T cells and NK cells. For all cells where there was an effect of ageing, the slope of the curve was greater for men than for women and this was statistically significant for CD8+αβ+T cells and CD3+CD45RA-CCR7-effector memory cells. There was also a difference for naïve cells but this was not significant.Conclusion: The cause of the change in percentage of lymphocyte subsets with age, and the different effects on males and females is not fully understood but warrants further study.

1 August 2004 in Stroke
Verified
Journal Article
Closed access
PDF file
JDJames P. Davis
James P. Davis
AWAndrew A. Wong
Andrew A. Wong
PSPhilip Schluter
Philip Schluter
RHRobert D. Henderson
Robert D. Henderson
JOJohn D. O’sullivan
John D. O’sullivan
SRStephen J. Read
Stephen J. Read
Background and Purpose— To assess the prevalence of premorbid undernutrition and its impact on outcomes 1 month after stroke. Methods— The study recruited from consecutive stroke admissions during a 10-month period. Premorbid nutritional status (using the subjective global assessment [SGA]), premorbid functioning (modified Rankin scale [MRS]), and stroke severity (National Institutes of Health Stroke Scale [NIHSS] score) were assessed at admission. The associations between premorbid nutritional status, poor outcome (defined as MRS ≥3), and mortality were examined before and after adjustment for confounding variables, including age, gender, stroke risk factors, stroke severity, and admission serum albumin. Results— Thirty of 185 patients were assessed as having undernutrition at admission. Significant unadjusted associations were observed between undernutrition and poor outcome (odds ratio [OR], 3.4; 95% CI, 1.3 to 8.7; P =0.01), and mortality (OR, 3.1, 95% CI, 1.3 to 7.7; P =0.02) at 1 month. NIHSS, age, and premorbid MRS were also significantly associated with poor outcomes. After adjustment for these factors, the effect size of associations remained important but not significant (poor outcome: OR, 2.4; 95% CI, 0.7 to 9.0, P =0.18; mortality: OR, 3.2; 95% CI, 1.0 to 10.4, P =0.05). Conclusions— Premorbid undernutrition, as assessed using the SGA, appears to be an independent predictor of poor stroke outcome. Stroke prevention strategies should target undernutrition in the population at risk for stroke to improve outcomes.